Your browser doesn't support javascript.
loading
Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
Mastrangelopoulou, Maria; Grigalavicius, Mantas; Raabe, Tine H; Skarpen, Ellen; Juzenas, Petras; Peng, Qian; Berg, Kristian; Theodossiou, Theodossis A.
Afiliación
  • Mastrangelopoulou M; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Grigalavicius M; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Raabe TH; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Skarpen E; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Juzenas P; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Peng Q; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Berg K; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Theodossiou TA; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Cancer Rep (Hoboken) ; 5(12): e1278, 2022 12.
Article en En | MEDLINE | ID: mdl-32737955
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fotoquimioterapia / Glioblastoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fotoquimioterapia / Glioblastoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Noruega